Cargando…
Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome
Acute respiratory distress syndrome (ARDS) is a serious complication of severe systemic or local pulmonary inflammation, such as caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. ARDS is characterised by diffuse alveolar damage that leads to protein-rich pulmonary oed...
Autores principales: | Gierhardt, Mareike, Pak, Oleg, Walmrath, Dieter, Seeger, Werner, Grimminger, Friedrich, Ghofrani, Hossein A., Weissmann, Norbert, Hecker, Matthias, Sommer, Natascha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489056/ https://www.ncbi.nlm.nih.gov/pubmed/34526314 http://dx.doi.org/10.1183/16000617.0059-2021 |
Ejemplares similares
-
Effects of hypercapnia and NO synthase inhibition in sustained hypoxic pulmonary vasoconstriction
por: Ketabchi, Farzaneh, et al.
Publicado: (2012) -
Diacylglycerol regulates acute hypoxic pulmonary vasoconstriction via TRPC6
por: Fuchs, Beate, et al.
Publicado: (2011) -
Nebulization of the acidified sodium nitrite formulation attenuates acute hypoxic pulmonary vasoconstriction
por: Egemnazarov, Bakytbek, et al.
Publicado: (2010) -
Surfactant alteration and replacement in acute respiratory distress syndrome
por: Günther, Andreas, et al.
Publicado: (2001) -
Decreased plasma levels of the brain-derived neurotrophic factor correlate with right heart congestion in pulmonary arterial hypertension
por: Schäfer, Katharina, et al.
Publicado: (2023)